CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Multisystem multifocal langerhans cell histiocytosis in an adult presenting with classical triad: lytic bone lesions, exophthalmos, and diabetes insipidus - a rare case report

Author: 
Dr. Hitesh Sharma, Dr. R L Meena, Dr. Shailendra Kumar Gupta, Dr. Rajveer Bunkar, Dr. Ravi Prakash Dadich, Dr. Ritu Meghwal and Dr. Dhupesh Manohar and Dr. Braj Raj Dagur
Subject Area: 
Health Sciences
Abstract: 

Langerhans Cell Histiocytosis (LCH) is a rare clonal disorder of antigen-presenting dendritic cells expressing CD1a, S-100, and Langerin (CD207). It may involve a single organ or multiple organ systems with variable severity. Adult-onset multisystem LCH is uncommon and easily misdiagnosed. We report a 28-year-old male presenting with the classical Hand-Schuller- Christian triad of osteolytic bone lesions, exophthalmos, and central diabetes insipidus . A skeletal survey and CT imaging revealed multifocal lytic lesions of skull, pelvis, and long bones with pulmonary and abdominal organ involvement. Histopathology confirmed LCH as CD1a+, S-100+ and Langerin(CD207) +. Management included systemic corticosteroids, vinblastine- based chemotherapy, and desmopressin, with counseling on smoking cessation and follow-up. This case underscores the need to recognize adult multisystem LCH to enable timely biopsy, risk stratification, and targeted therapy.

PDF file: 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

MIEZAN Essou Koffi Benjamin
Côte d’Ivoire
Dr. Govindaiah Simuni
USA
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran